Build to Scale Reauthorization Act of 2026
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
The Build to Scale Reauthorization Act of 2026 aims to renew and strengthen the regional innovation program established by the Stevenson-Wydler Technology Innovation Act of 1980. Specifically, it modifies the program to increase access to capital for innovation-based businesses, shift the focus from strategies to initiatives, and expand outreach to underserved communities. The act also clarifies the role of venture development organizations and establishes a funding mechanism for the program.
Key provisions
- Increases access to capital for innovation-based businesses through venture development organizations.
- Shifts the program’s focus from ‘strategies’ to ‘initiatives’.
- Expands outreach to rural communities, communities impacted by trade, and areas with economic distress.
- Clarifies the definition of a ‘venture development organization’.
- Requires a minimum Federal cost share of 50% for regional innovation activities, with an additional 40% based on area needs.
- Authorizes the use of previously unobligated funds for program activities.
- Provides for a fixed appropriation of $50,000,000 per year from 2026 through 2030.
- Includes the Regional Technology and Innovation Hub Program within the program's framework.
Who is affected
- State and nonprofit organizations
- Private innovation-centered businesses
- Rural communities
- Communities negatively impacted by trade
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
6 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours